insights_auto
Kwa nini HALO imeongezeka kwa 13.02%?
Fahamu zaidichevron_right
HALO:BMV
Halozyme Therapeutics, Inc.
MX$ 2,225.00
arrow_upward
+13.02%(+256.31) Siku 1
15 Okt, 14:00:00 GMT -6 · MXN
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya HALO...
Fungua
MX$ 2,225.00
Juu
MX$ 2,225.00
Chini
MX$ 2,225.00
Mtaji wa soko
13.79B
Wastani wa kiasi cha mauzo
440.00
Kiasi cha mauzo ya hisa
50.00
Juu kwa wiki 52
MX$ 2,225.00
Chini kwa wiki 52
MX$ 1,126.00
Idadi ya wafanyakazi
423
Fungua
MX$ 2,225.00
Juu
MX$ 2,225.00
Chini
MX$ 2,225.00
Mtaji wa soko
13.79B
Wastani wa kiasi cha mauzo
440.00
Kiasi cha mauzo ya hisa
50.00
Juu kwa wiki 52
MX$ 2,225.00
Chini kwa wiki 52
MX$ 1,126.00
Idadi ya wafanyakazi
423
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
CNBC
·
saa 2 zilizopita
Inside Edge’s Todd Gordon: Halozyme Therapeutics are beating estimates; raised full-year guidance
Yahoo Finance
·
saa 10 zilizopita
Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today
Timothy Sykes
·
siku 1 iliyopita
HALO Stock Climbs As Dutch Court Injunction Lifts Bullish Bets
StocksToTrade
·
siku 1 iliyopita
HALO Stock Climbs As Patent Win And Deals Lift Outlook
Wasifu
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
Kuhusu Halozyme Therapeutics, Inc.
Afisa Mkuu Mtendaji (CEO)Helen I. Torley
Wafanyakazi423
Lilianzishwa1998
Makao makuuSan Diego, California, Marekani
Sekta-
Tovutihalozyme.com